Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of
treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat
pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque
psoriasis.